Introduction
Matrix vesicles (MVs) are small vesicles with a diameter of 50-200 nm, which contain abundant phospholipid and protein components and play an important role in the process of bone mineralization (1) . It has been reported that a MV protein deficiency might participate in the pathological mineralization process of many rare skeletal diseases (2) . Recently, the protein profiling of MVs from different origins were analyzed in several proteomic studies, and more than 2,000 proteins have been identified in MVs including several validated mineralization-related proteins such as alkaline phosphatase (TNAP), and annexins (3) (4) (5) (6) . However, the roles of most of the MV proteins in mineralization regulation remain unclear.
Saos-2 is a human osteoblast-like cell line having significant mineralization ability under osteogenic induction. Meanwhile, another human osteoblast-like cell U2-OS has low phosphate enzyme activity and could not be mineralized after induction (7) . Therefore, we speculated that the difference among MV proteins between Saos-2 and U2-OS cells could provide novel clues to clarify the exact roles of MVs during the mineralization process.
In this study, we performed a label-free LC-MSMS proteomic approach to compare the MV protein profiles between Saos-2 and U2-OS cells in order to further screen functional MV proteins for mineralization regulation. 
Materials and Methods

Cell culture and osteogenic induction
Mineralization detection by Alizarin Red staining
Saos-2 and U2-OS cells were plated in 24-well plates for induction, and mineralization levels were assessed by alizarin red staining during induction (0 days, 3 days, and 7 days). The cells were washed with PBS and fixed with 4% paraformaldehyde. Then the cells were washed with PBS and stained with 0.5% (w/v) alizarin red S solution for 1 h. After washing with PBS, the stained cultures were photographed.
Matrix vesicles extraction by ExoQuick solution
Cells were washed with PBS without calciummagnesium ions 3 times, and then collagenase (2 mL, 1 mg/mL) was added. Supernatant was collected and centrifuged at 3,000 rpm for 30 min at 4°C, transferred into a 100 kD ultrafiltration concentrator tube (Millipore, Billerica, MA, USA) and centrifuged at 3,000 rpm for 30 min at 4°C to concentrate to about 1 mL. The concentrated liquid was mixed with the ExoQuick Exosome Isolation Reagent (System Biosciences, Mountain View, CA, USA) at 4°C overnight. The mixture was centrifuged at 3000 rpm for 30 min at 4°C to sediment MVs.
Transmission electron microscopy validation for matrix vesicles
Freshly isolated MVs pellets were first fixed with 3% glutaraldehyde at 4°C for 2 h, and then post-fixed in 1% osmium tetroxide for 1 h. After dehydration in a graded ethanol series with acetone, samples were embedded in epoxy resin. 75 nm thick semithin sections were mounted on copper grids, and stained with uranyl acetate while lead citrate solutions were used to enhance the contrast. Electron micrographs were observed on a H800 transmission electron microscope (TEM) (Hitachi Electronic Instruments, Tokyo, Japan).
LC-MS/MS analysis and label-free quantification
MVs protein samples were extracted by adding 200 μL SDT buffer containing 4% SDS, 150 mM Tris (pH 8.0). After heating and sonication, the lysates were centrifuged (10,000 g, 1 h, 4°C) and the supernatants were collected. The protein concentrations were assayed with a standard Bradford protein assay (Bio-Rad Laboratories, Hercules, CA, USA). 150 μg of MVs protein samples from U2-OS and Saos-2 cells (with and without mineralization induction) were digested by a filteraided sample preparation (FASP) method as described previously (8) . Mass analyses were performed on a Q Exactive mass spectrometer. MS/MS spectra were searched against the nonredundant Inter-national Protein Index (IPI) human protein database or Swissprot database. Label-free quantitative analyses were performed as described previously (9) . MaxQuant output files were uploaded into a Perseus package for calculation of significant scores. Proteins with scores that varied more than 2 fold were defined as significantly differentially expressed.
Western-blots
Equal amounts (25 µg) of MVs protein samples were separated on a 12% SDS-PAGE gel, and transferred to PVDF membranes (Millipore), and then probed with primary antibodies against protein kinase C α (Ptglab, 1:1000 dilution) and ras-related protein (Ptglab, 1:1000 dilution) overnight at 4°C, followed by peroxidaseconjugated secondary antibodies. Finally, the bands were visualized using ECL reagents (Millipore) according to the manufacturer's instructions.
Results
After osteogenic induction, Saos-2 cells demonstrated a time-dependent increase in mineralized nodule formation assessed by Alizarin Red staining, while mineralization was absent in the matrix of U2-OS cells (Figure 1 ). Using ExoQuick reagents, MVs were successfully precipitated, and were validated by up-regulated MV proteins in Saos-2 cells (protein kinase C α and ras-related protein Ral-A) were selected for validation by Western blotting. We detected that both MVs proteins were overexpressed in Saos-2 cells compared to U2-OS cells, which is consistent with our proteomic findings (Figure 3 ).
Discussion
Matrix vesicles have been implicated in pathological mineralization events, which are characteristic of multiple rare diseases. In this study, we compared the MVs protein profiles between mineralization-competent cells Saos-2 and mineralization incompetent cells U2-OS. We identified a panel of differentially expressed proteins at MVs levels associated with mineralization, which could provide novel clues for mining the regulatory details of mineralization.
We performed a GO analysis on 89 up-regulated MV proteins in Saos-2 cells. In molecular function analysis, differentially expressed proteins were mainly transmission electron microscopy. As seen in Figure  2 , the precipitation by ExoQuick reagents recognized spherical membrane-bound vesicle structures with diameters ranging from 50 to 200 nm, and part of the vesicles contained electron dense material.
In the proteomic study, we identified a total of 175 differentially expressed proteins (fold > 2) in Saos-2 MVs compared with U2-OS MVs, including 89 upregulated proteins and 86 down-regulated proteins (Supplemental data, Table 1S (http://www.irdrjournal. com/docindex.php?year=2013&kanno=2)). Among the up-regulated MVs proteins, alkaline phosphatase (ALP) ranked as the most significantly increased MVs protein in Saos-2 cells, which has been proved in many studies. 89 up-regulated proteins were further classified on Gene Ontology in terms of biological processes (Table 1 ) and molecular function (Table 2) using the MAS 3.0 software (CapitalBio, Beijing, China). In particular, we observed that 12 up-regulated MVs proteins of Saos-2 cells belong to calcium ion binding proteins (GO: 0005509).
To confirm the results of our proteomic study, two (14) . Phospholipase D is engaged in a high rate of hydrolysis of neutral phospholipids and a lower rate of degradation of anionic phospholipids, which allows mineral formation in MVs (15) . It has been proposed that ras-related protein Ral-A is involved in the tyrosine kinase-mediated, Ras-dependent activation of phospholipase D (16) . In our study, we confirmed that Ral-A also exists as a MVs component, and suggests that its interaction with phospholipase D in MVs might participate in the regulation of the mineralization process.
In conclusion, in this study we identified a series of MVs proteins specifically up-regulated in mineralization competent osteoblasts, which might provide new clues to study the mechanism for mineralization control in the extracelluar matrix. We also confirmed that protein kinase C α and ras-related protein Ral-A are novel MVs proteins and might be involved in bone mineralization as MVs components.
